Key Findings:  This narrative review synthesizes preclinical and emerging clinical evidence on Cannabis sativa–derived terpenes, highlighting their analgesic and anti-inflammatory mechanisms, potential synergy with cannabinoids, and the need for standardized formulations and rigorous clinical studies to advance their therapeutic application in chronic pain.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  Italy
Year of Pub:  2025
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  ß-Caryophyllene, Humulene, Limonene, Linalool, Myrcene, Pinene
Receptors Studied:  CB2
Ligands Studied:  Pro-inflammatory cytokines
Citation:  Alfieri A, Di Franco S, Maffei V, Sansone P, Pace MC, Passavanti MB, Fiore M. Phytochemical Modulators of Nociception: A Review of Cannabis Terpenes in Chronic Pain Syndromes. Pharmaceuticals (Basel). 2025 Jul 24;18(8):1100. doi: 10.3390/ph18081100. PMID: 40872493; PMCID: PMC12389225.